Igenica appoints Genentech's Gwen Fyfe to board
This article was originally published in Scrip
Californian antibody developer Igenica has appointed Dr Gwen Fyfe to the company's board of directors. At Genentech, Dr Fyfe serves as vice-president of oncology development and vice-president of the Avastin Franchise team. She also serves on the boards of Array BioPharma and Infinity Pharmaceuticals.